Pathophysiological Impact of the MEK5/ERK5 Pathway in Oxidative Stress

Cells. 2023 Apr 13;12(8):1154. doi: 10.3390/cells12081154.

Abstract

Oxidative stress regulates many physiological and pathological processes. Indeed, a low increase in the basal level of reactive oxygen species (ROS) is essential for various cellular functions, including signal transduction, gene expression, cell survival or death, as well as antioxidant capacity. However, if the amount of generated ROS overcomes the antioxidant capacity, excessive ROS results in cellular dysfunctions as a consequence of damage to cellular components, including DNA, lipids and proteins, and may eventually lead to cell death or carcinogenesis. Both in vitro and in vivo investigations have shown that activation of the mitogen-activated protein kinase kinase 5/extracellular signal-regulated kinase 5 (MEK5/ERK5) pathway is frequently involved in oxidative stress-elicited effects. In particular, accumulating evidence identified a prominent role of this pathway in the anti-oxidative response. In this respect, activation of krüppel-like factor 2/4 and nuclear factor erythroid 2-related factor 2 emerged among the most frequent events in ERK5-mediated response to oxidative stress. This review summarizes what is known about the role of the MEK5/ERK5 pathway in the response to oxidative stress in pathophysiological contexts within the cardiovascular, respiratory, lymphohematopoietic, urinary and central nervous systems. The possible beneficial or detrimental effects exerted by the MEK5/ERK5 pathway in the above systems are also discussed.

Keywords: ERK5; KLF2/4; MEF2; RNS; ROS; antioxidant response; oxidative damage; oxidative stress.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Antioxidants* / metabolism
  • Humans
  • MAP Kinase Kinase 5 / genetics
  • MAP Kinase Kinase 5 / metabolism
  • Mitogen-Activated Protein Kinase 7* / genetics
  • Mitogen-Activated Protein Kinase 7* / metabolism
  • Oxidative Stress
  • Reactive Oxygen Species

Substances

  • Antioxidants
  • MAP Kinase Kinase 5
  • Mitogen-Activated Protein Kinase 7
  • Reactive Oxygen Species

Grants and funding

The research in Elisabetta Rovida’s lab is supported by Associazione Italiana per la Ricerca sul Cancro (AIRC, IG-15282 and IG-21349), Ente Cassa di Risparmio di Firenze (ECRF), Università degli Studi di Firenze (“Progetto Competitivo di Ateneo per Ricercatori” funded by MUR and Next Generation EU). Alessandro Tubita is supported by a “Carlo Zanotti” Fondazione Italiana per la Ricerca sul Cancro (FIRC)-AIRC fellowship (ID-23847).